Changes in Thymopoiesis in Myasthenia Gravis

REFERENCES

• Aime C., Cohen-Kaminsky S., Berrih-Aknin S. In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis. Journal of Clinical Immunology 1991; 11((5))268–278
   PubMedGoogle Scholar
• Berrih-Aknin S., Morel E., Gaud C., Raimond F., Le Brigand H., Bach J. P. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Neurology 1984; 34((1))66–71
   PubMedGoogle Scholar
• Berrih-Aknin S., Cohen-Kiminsky S., Neumann D., Safar D., Eymard B., Gaud C., Levasseur D., Fuels S., Bach J. F. Cellular aspects of myasthenia gravis. Immunological Research 1988; 7((3))189–199
   PubMedGoogle Scholar
• Budd R. C., Mixter P. F. The origin of CD4-CD8-TCRαβ thymocytes: A model based on T-cell receptor avidity. Immunology Today 1995; 16((9))428–431, [CROSSREF]
   PubMedGoogle Scholar
• Capone M., Hockett R. D., Jr., Zlotnik A. Kinetics of T cell receptor beta, gamma, and delta rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44(+)CD25(+) Pro-T thymocytes. Proceedings of the National Academy of Science USA 1998; 95((21))12522–12527, [CROSSREF]
   PubMedGoogle Scholar
• Chan S. H., Cosgrove D., Waltzinger C., Benoist C., Mathis D. Another view of the selective model of thymocyte selection. Cell 1993; 73((2))225–236, [CROSSREF]
   PubMedGoogle Scholar
• Christadoss P., Lindstrom J. M., Melvold R. W., Talal N. Mutation of I-Abeta chain prevents experimental myasthenia gravis. Journal of Immunogenetics 1985; 21((1))31–38
   Google Scholar
• Fridkis-Hareli M., Eren R., Sharp A., Abel L., Kukulansky T., Globerson A. MHC recognition in colonization of the thymus by bone marrow cells. Cellular Immunology 1993; 149((1))91–98
   PubMedGoogle Scholar
• Fuji N., Itoyama Y., Goto I. Increase in differentiated type of T lineage cells in the myasthenic thymus: Two-color fluorocytometric analysis. Annals of Neurology 1990; 27((2))642–646, [CROSSREF]
   PubMedGoogle Scholar
• Fukuhara K., Okumura M., Shiono H., Inoue M., Kadota Y., Miyashi S., Matsuda H. A study on CD45 isoform expressed during T-cell development and selection events in the human thymus. Human Immunology 2002; 63((5))394–404, [CROSSREF]
   PubMedGoogle Scholar
• Ichikawa Y., Shimizu H., Yoshida M., Arimori S. Two-color flow cytometric analysis of thymic lymphocytes from patients with myashenia gravis and/or thymoma. Clinical Immunology Immunopathology 1992; 62((1Pt))91–96, [CROSSREF]
   PubMedGoogle Scholar
• Jameson S. C., Hogquist K. A., Bevan M. J. Positive selection of thymocytes. Annual Review of Immunology 1995; 13: 93–126, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaul R., Shenoy M., Goluszko E., Christadoss P. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. Journal of Immunology 1994; 152((6))3152–3157
   PubMedGoogle Scholar
• Lee P. T., Benlagha K., Teyton L., Bendelac A. Distinct functional lineages of human Va24 natural killer T cells. Journal of Experimental Medicine 2002; 195((5))637–641, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leprince C., Cohen-Kaminsky S., Berrih-Aknin S., Vernet Der Garabedian B., Treton D., Galanaud P., Richard Y. Thymic B cells from myasthenia gravis patients are activated B cells: Phenotypic and functional analysis. Journal of Immunology 1990; 145((7))2115–2122
   PubMedGoogle Scholar
• Levine G., Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Human Pathology 1978; 9((5))495–515
   PubMedGoogle Scholar
• Lind E. F., Prockop S. E., Porritt H. E., Petrie H. T. Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. Journal of Experimental Medicine 2001; 194((2))127–134, [CROSSREF]
   PubMedGoogle Scholar
• MacDonald H. R., Radtke F., Wilson A. T cell fate specification and alfa-beta/gamma-delta lineage commitment. Current Opinion in Immunology 2001; 13((2))219–224, [CROSSREF]
   PubMedGoogle Scholar
• Mehr R., Perelson A. S., Fridkis-Hareli M., Globerson A. Regulatory feedback pathways in the thymus. Immunology Today 1997; 18((12))581–585, [CROSSREF]
   PubMedGoogle Scholar
• Molinar S., Szobor A. Myasthenia gravis: Effect of thymectomy in 425 patients; a 15-year experience. European Journal of Cardiothorac Surgery 1990; 4((1))8–14
   PubMedGoogle Scholar
• Mower D. A., Peckham D. W., Illera V. A., Fishbaugh J. K., Stunz L. L., Ashman R. F. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. Journal of Immunology 1994; 152((10))4832–4842
   PubMedGoogle Scholar
• Osserman K. E., Genkins G. Studies in myasthenia gravis: Review of twenty-year experience in over 1200 patients. Mount Sinai Journal of Medicine 1971; 38((6))497–537
   PubMedGoogle Scholar
• Papiernik M., de Moraes M. L., Pontoux C., Vasseur F., Penit C. Regulatory CD4 T cells: Expression of IL-2R a-chain, resistance to clonal deletion and IL-2 dependency. International Immunology 1998; 10((4))371–378, [CROSSREF]
   PubMedGoogle Scholar
• Petrie H. T., Hugo P., Scollay R., Shortman K. Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4 and CD8 acquisition in vivo and in vitro. Journal of Experimental Medicine 1990; 172((6))1583–1588, [CROSSREF]
   PubMedGoogle Scholar
• Ragheb S., Lisak R. P. The immunopathogenesis of acquired (autoimmune) myasthenia gravis. Handbook of myasthenia gravis and myasthenic syndromes, S. Ragheb, R. P. Lisak. Dekker, New York 1994; 239–276
   Google Scholar
• Reinhardt C., Melms A. Normalization of elevated CD4−/CD8− (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma. Annals of Neurology 2000; 48((4))603–608
   PubMedGoogle Scholar
• Roncarolo M. G., Levings M. K. The role of different subsets of T regulatory cells in controlling autoimmunity. Current Opinion in immunology 2000; 12((6))676–683
   PubMedGoogle Scholar
• Salakou S., Tsamandas A. C., Bomkos D. S., Papapetropoulos T., Dougenis D. The potential role of bcl-2, bax and Ki67 expression in thymus of patient with myasthenia gravis and their correlation with clinicopathological parameters. European Journal of Cardiothorac Surgery 2001; 20((4))712–721, [CROSSREF]
   PubMedGoogle Scholar
• Schönbeck S., Padberg F., Hohfield R., Wekerle H. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. Journal of Clinical Investigations 1992; 90((1))245–250
   PubMedGoogle Scholar
• Scollay R., Godfrey D. I. Thymic emigration: Conveyor belts or lucky dips?. Immunology Today 1995; 16((6))268–273, [CROSSREF]
   PubMedGoogle Scholar
• Seddon B., Mason D. The third function of the thymus. Immunology Today 2000; 21((2))95–99, [CROSSREF]
   PubMedGoogle Scholar
• Starr T. K., Jameson S. C., Hogquist K. A. Positive and negative selection of T cells. Annual Review of Immunology 2003; 21: 139–176, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Taams L. S., Wauben H. M. Anergic T cells as active regulators of immune response. Human Immunology 2000; 61((7))633–639, [CROSSREF]
   PubMedGoogle Scholar
• von Boehmer H., Aifantis I., Feinberg J., Lechner O., Saint-Ruf C., Walter U., Buer J., Azogui O. Pleiotropic changes controlled by the pre-T-cell receptor. Current Opinion in Immunology 1999; 11((2))135–142, [CROSSREF]
   PubMedGoogle Scholar
• Wallace V. A., Fung-Leung W. P., Timms E., Grey D., Kishihara K., Loh D. Y., Penninger J., Mak T. W. CD45RA and CD45RB high expression induced by thymic selection events. Journal of Experimental Medicine 1992; 176((6))1654–1663
   Google Scholar
• Wallace V. A., Penninger J. M., Kishihara K., Timms E., Shahinian A., Pircher H., Kündig T. M., Ohashi P. S., Mak T. W. Alterations in the level of CD4S surface expression affect outcome of thymic selection. Journal of Immunology 1997; 158((7))3205–3214
   PubMedGoogle Scholar
• Wang R., Wang-Zhu Y., Grey H. Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proceedings of the National Academy of Science USA 2002; 99((4))2181–2186, [CROSSREF]
   PubMedGoogle Scholar
• Westermann J., Smith T., Peters U., Tschernig T., Pabst R., Steinhoff G., Sparshott S. M., Bell E. B. Both activated and non-activated leucocytes from the periphery continuously enter the thymic medulla of adult rats: Phenotypes, source and magnitude of traffic. European Journal of Immunology 1996; 26((8))1866–1874
   PubMedGoogle Scholar